Pevonedistat Plus Azacitidine for Patients With Higher-Risk MDS, CMML, and AML: Mikkael A. Sekeres, MD
Keira Smith
Expert Analysis
For older patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML) with 20% to 30% marrow blasts, treatment options are limited. In the PANTHER study, the results of which were recently presented at the American Society of Hematology (ASH) 63rd Annual Meeting & Exposition...
CARG Chemotherapy Toxicity Calculator Found Not Valid for Older Patients With Hematologic Malignancies: Ashley Rosko, MD
Keira Smith
Expert Analysis
Understanding the balance between effective treatments and health-related quality of life is crucial, especially when treating older adults with hematologic malignancies. The Cancer and Aging Research Group (CARG) chemotherapy toxicity calculator has been sufficiently studied and utilized in patients with solid tumors; however, its efficacy in the ...
Safely Reducing Patient Hospital Stay After CAR T-Cell Therapy: Remote Patient Monitoring With Morie Gertz, MD
Keira Smith
Expert Analysis
While chimeric antigen receptor (CAR) T-cell therapies have revolutionized the treatment landscape for patients with hematologic malignancies, challenges remain in the management of short-term toxicities, most notably cytokine release syndrome and neurologic symptoms. In nearly all cases to date, optimal management has only been achieved through in...
Applying Recent Advances to Personalized Breast Cancer Care, A Breast Surgical Oncologist’s View: Brigid Killelea, MD, FACS
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Applying Recent Advances to Personalized Breast Cancer Care: Brigid Killelea, MD, FACS Over recent years, numerous developments have occurred in the fields of breast cancer prevention, genetic testing, screening, and surgical procedures. In this interview, Dr. Brigid Killelea, Medical Director of Breast Surgery at Hartford HealthCare, explains strategies for incorporating these advances into the care of patients with breast cancer.
The Significance of nab-Sirolimus and Future Directions in the Treatment of Perivascular Epithelioid Cell Tumor (PEComa): Richard F. Riedel, MD
Selma Khenissi, MPS
Expert Analysis
Recently, the FDA granted approval to nanoparticle albumin-bound sirolimus (nab-sirolimus) for the treatment of patients with metastatic malignant perivascular epithelioid cell tumor (PEComa). Dr. Richard F. Riedel, Associate Professor of Medicine at Duke University, was one of the investigators of the AMPECT study, on which the approval was based....
Applying Recent Advances to Personalized Breast Cancer Care, A Breast Surgical Oncologist’s View: Brigid Killelea, MD, FACS
Keira Smith
Expert Analysis
Brigid Killelea, MD, FACS. Over recent years, numerous developments have occurred in the fields of breast cancer prevention, genetic testing, screening, and surgical procedures. In this interview, Dr. Brigid Killelea, Medical Director of Breast Surgery at Hartford HealthCare, explains strategies for incorporating these advances into the care of patients with breast cancer.  
Making Strides in Breast Cancer Treatment With Richard Zelkowitz, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Making Strides in Breast Cancer Treatment With Richard Zelkowitz, MD Significant progress has been made in numerous facets of breast cancer care in recent years, including developments in treatment, imaging, pathology, radiation, and surgery. In this interview, Dr. Richard Zelkowitz, a Regional Medical Director of the Breast Program at Hartford HealthCare, highlights the advances that have been made and explains the importance of subspecialties in ensuring that patients with breast cancer receive the most individualized care possible.  
Insights Into Breast Cancer Treatment and Management During the COVID-19 Pandemic: Valerie Brutus, MD, FACS
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Insights Into Breast Cancer Treatment and Management in the COVID-19 Pandemic: Valerie Brutus, MD For patients with breast cancer, the approach to treatment requires an individualized approach accounting for factors such as genetic risk, symptom management, and more recently, the challenges of the COVID-19 pandemic. In this interview, Dr. Valerie Brutus, a breast surgical oncologist at St. Vincent's Medical Center of Hartford HealthCare, discusses strategies for successfully incorporating each of these factors into patients' treatment.  
Making Strides in Breast Cancer Treatment With Richard Zelkowitz, MD
Keira Smith
Expert Analysis
Richard Zelkowitz, MD. Significant progress has been made in numerous facets of breast cancer care in recent years, including developments in treatment, imaging, pathology, radiation, and surgery. In this interview, Dr. Richard Zelkowitz, a Regional Medical Director of the Breast Program at Hartford HealthCare, highlights the advances that have been made and explains the importance of subspecialties in ensuring that patients with breast cancer receive the most individualized care possible.  
Furthering Clinical Trials and Improving Outcomes for Patients With Lung Cancer: Ross Camidge, MD, PhD
Elizabeth Heller, PhD
Expert Analysis
The outcomes of patients with lung cancer have improved significantly in recent years, largely due to the treatment targeting the cancer's specific genetic profile and the impact of immunotherapy, often in different groups of patients. In this interview, Ross Camidge, MD, PhD, Director of Thoracic Oncology at the University of Colorado Cancer Cente...
Insights Into Breast Cancer Treatment and Management During the COVID-19 Pandemic: Valerie Brutus, MD, FACS
Keira Smith
Expert Analysis
Valerie Brutus, MD, FACS. For patients with breast cancer, the approach to treatment requires an individualized approach accounting for factors such as genetic risk, symptom management, and more recently, the challenges of the COVID-19 pandemic. In this interview, Dr. Valerie Brutus, a breast surgical oncologist at St. Vincent's Medical Center of Hartford HealthCare, discusses strategies for successfully incorporating each of these factors into patients' treatment.
Breast Cancer Awareness Month: A Panel Discussion With Christine Samuel, Mikel Ross, and Lillie Shockney
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Breast Cancer Awareness Month With Christine Samuel, Mikel Ross, and Lillie Shockney In this recording of Oncology Data Advisor's Live Breast Cancer Panel, three noted experts in breast cancer management partake in a conversation about recent advances in treatment, strategies and integrative medicine modalities to minimize toxicity, and techniques for enabling patients with breast cancer to thrive throughout their diagnosis and treatment.  
Hopeful Developments in the Survival Rate for Patients With Extensive-Stage Small Cell Lung Cancer: Insights from Anne Chiang, MD, PhD
Selma Khenissi, MPS
Expert Analysis
Anne Chiang, MD, PhD. Patients with extensive-stage small cell lung cancer (SCLC) are experiencing better survival rates than they have in past years. In honor of Lung Cancer Awareness Month, Anne Chiang, MD, PhD, Chief Integration Officer and Deputy Chief Medical Officer of Smilow Cancer Hospital and Associate Professor in the Section of Medical Oncology at Yale School of Medicine, discusses recent developments that have led to improvements in survival rates, as well as also exciting new developments to come in the treatment of patients with extensive-stage small cell lung cancer.
How to Help Breast Cancer Survivors Become Breast Cancer Thrivers: Lillie Shockney, RN, BS, MAS, HON-ONN-CG
Keira Smith
Expert Analysis
Oncology Data Advisor™ · How to Help Breast Cancer Survivors Become Breast Cancer Thrivers: Lillie Shockney, RN How can members of the cancer care team enable breast cancer survivors to become breast cancer thrivers? Watch as Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation Medical Advisory Council, explains how to provide optimal care and support for patients with breast cancer during their treatment and beyond.  
The Changing Treatment Landscape for Renal Cell Carcinoma: Bradley McGregor, MD
Keira Smith
Expert Analysis
Within the last few years, treatment of renal cell carcinoma has improved dramatically, with FDA approvals of several agents and numerous others in development. In this interview, Bradley McGregor, MD, Clinical Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard Medical Sch...
Breast Cancer and Pandemic Challenges: Mammograms and Vaccines With Lillie Shockney, RN, BS, MAS, HON-ONN-CG
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Breast Cancer and Pandemic Challenges With Lillie Shockney, RN, BS, MAS, HON-ONN-CG Although the management of breast cancer has been impacted by the COVID-19 pandemic, the cancer care team has developed strategies to optimize screening and treatment experiences in spite of these challenges. In this interview, ...
Applying Precision Medicine in BRAF V600E-Mutant Metastatic Colorectal Cancer: Aparna Parikh, MD, MS, and Theresa Gillespie, PhD, MA, RN, FAAN
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Applying Precision Medicine in BRAF V600E-Mutant Metastatic Colorectal Cancer Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected ...
Utilizing Biomarker Testing to Improve Lung Cancer Survival: Beth Sandy, MSN, CRNP
Keira Smith
Expert Analysis
The survival rate for lung cancer has improved significantly in recent years, largely due to the adoption of biomarker testing and the development of targeted therapies. In this interview in honor of Lung Cancer Awareness Month, Beth Sandy, MSN, CRNP, Outpatient Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer ...
Overcoming Pandemic Challenges in Breast Cancer Care With Erin Prendergast, RN, CBCN®
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Overcoming Pandemic Challenges in Breast Cancer Care With Erin Prendergast, RN, CBCN® This latest interview for Breast Cancer Awareness Month features Erin Prendergast, RN, CBCN®, an oncology nurse navigator and Senior Breast Clinical Coordinator in the Breast Cancer Program at UT Southwestern Simmons Comprehensive Cancer Center. Ms. Prendergast explains what she does in her role as an oncology nurse navigator and shares strategies that her team has implemented to ensure that patients with breast cancer receive optimal access to treatment and supportive care during the COVID-19 pandemic.
Enhancing Quality of Life Preservation and Restoration in Breast Cancer With Lillie Shockney, RN, BS, MAS, HON-ONN-CG
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Enhancing Quality of Life in Breast Cancer With Lillie Shockney, RN, BS, MAS How can members of the cancer care team help their patients with breast cancer continue to thrive despite their diagnosis? Watch as Lillie Shockney, RN, BS, MAS, HON-ONN-CG, Professor of Surgery at Johns Hopkins University and member of the National Breast Cancer Foundation Medical Advisory Council, shares how to enhance quality of life preservation and restoration for breast cancer patients and survivors. 

Copyright © 2022 Oncology Data Advisor. All rights reserved.